0,986  0,002  Respiratory analeptic
0,964  0,002  CYP2C9 substrate
0,948  0,002  Analeptic
0,941  0,003  CYP1A2 substrate
0,937  0,003  CYP2D6 substrate
0,930  0,005  Apoptosis agonist
0,926  0,002  NOS2 expression inhibitor
0,925  0,004  Transcription factor NF kappa B inhibitor
0,915  0,004  Cardiotonic
0,896  0,005  Antineoplastic (breast cancer)
0,885  0,004  CYP2C19 substrate
0,878  0,005  Antineoplastic (lung cancer)
0,860  0,004  Antineoplastic (ovarian cancer)
0,860  0,006  CYP3A4 substrate
0,855  0,003  UGT1A6 substrate
0,830  0,003  Anesthetic
0,829  0,004  Chemopreventive
0,822  0,002  UGT1A1 substrate
0,824  0,005  Prostate cancer treatment
0,814  0,006  Antineoplastic (colorectal cancer)
0,804  0,004  Antineoplastic (cervical cancer)
0,803  0,007  Antineoplastic (colon cancer)
0,799  0,004  Heart failure treatment
0,791  0,003  Hypoxia-inducible factor 1 alpha inhibitor
0,774  0,005  Antineoplastic (melanoma)
0,773  0,011  Teratogen
0,757  0,004  Muscle relaxant
0,757  0,005  Cytotoxic
0,753  0,010  TNF expression inhibitor
0,746  0,005  Proliferative diseases treatment
0,739  0,009  Carcinogenic
0,740  0,012  Embryotoxic
0,716  0,004  Diuretic
0,712  0,005  Antineoplastic (glioma)
0,704  0,006  NOS3 expression inhibitor
0,688  0,005  Antineoplastic (pancreatic cancer)
0,684  0,004  Antineoplastic (sarcoma)
0,693  0,014  Antileukemic
0,685  0,011  Antihypercholesterolemic
0,697  0,031  Antiinflammatory
0,668  0,005  Antineoplastic (renal cancer)
0,650  0,005  UDP-glucuronosyltransferase substrate
0,624  0,009  Nitric oxide antagonist
0,624  0,015  Cholesterol antagonist
0,614  0,006  UGT1A4 substrate
0,581  0,000  Na+ K+ transporting ATPase inhibitor
0,583  0,004  Transcription factor STAT3 inhibitor
0,590  0,012  Cytostatic
0,579  0,013  Hepatic disorders treatment
0,561  0,005  Antineoplastic (liver cancer)
0,554  0,005  UGT2B4 substrate
0,550  0,005  Transcription factor STAT inhibitor
0,546  0,008  Antineoplastic (lymphoma)
0,539  0,005  UGT1A3 substrate
0,542  0,016  AR expression inhibitor
0,546  0,021  Immunosuppressant
0,537  0,014  Antineoplastic (non-small cell lung cancer)
0,526  0,007  P-glycoprotein inhibitor
0,520  0,009  Antihypoxic
0,523  0,011  Antineoplastic (glioblastoma multiforme)
0,511  0,003  UGT2B9 substrate
0,523  0,017  Antineoplastic (brain cancer)
0,510  0,005  Contraceptive
0,522  0,021  Sensitization
0,543  0,046  Caspase 9 stimulant
0,498  0,005  UGT2B7 substrate
0,503  0,011  ICAM1 expression inhibitor
0,495  0,008  Anesthetic general
0,502  0,023  CYP2C19 inhibitor
0,482  0,006  Sulfotransferase substrate
0,495  0,021  Caspase 3 stimulant
0,473  0,005  Sodium/bile acid cotransporter inhibitor
0,470  0,026  Cardioprotectant
0,449  0,006  UGT2B15 substrate
0,454  0,012  Antihelmintic
0,448  0,009  Abortion inducer
0,465  0,026  Lipoprotein disorders treatment
0,453  0,015  Antineoplastic (endocrine cancer)
0,463  0,029  Antifungal
0,439  0,009  Antineoplastic (squamous cell carcinoma)
0,448  0,019  Antiparasitic
0,437  0,010  Hepatoprotectant
0,433  0,006  Lipocortins synthesis antagonist
0,472  0,049  Antibacterial
0,445  0,028  Apoptosis antagonist
0,422  0,008  Skeletal muscle relaxant
0,425  0,012  Antineoplastic (carcinoma)
0,434  0,040  Bone diseases treatment
0,411  0,019  Antineoplastic enhancer
0,413  0,026  DNA damaging
0,395  0,011  Prostate disorders treatment
0,428  0,056  Antipruritic, allergic
0,374  0,005  Cholesterol synthesis inhibitor
0,401  0,035  Antioxidant
0,392  0,027  Hypolipemic
0,372  0,008  Antidiarrheal
0,368  0,005  Androgen antagonist
0,352  0,005  Contraceptive male
0,388  0,044  Antihypertensive
0,380  0,044  Radioprotector
0,339  0,010  Neurotrophic factor enhancer
0,367  0,043  CYP3A4 inhibitor
0,364  0,041  Chemoprotective
0,364  0,045  Antiosteoporotic
0,351  0,041  Antiprotozoal (Leishmania)
0,326  0,019  Prostatic (benign) hyperplasia treatment
0,340  0,035  Antimitotic
0,308  0,005  ATPase inhibitor
0,338  0,041  Cardiovascular analeptic
0,319  0,026  Antiviral (Influenza)
0,337  0,050  UGT1A9 substrate
0,306  0,021  Antipruritic, non-allergic
0,283  0,005  Aromatase inhibitor
0,328  0,050  Antineoplastic (multiple myeloma)
0,318  0,043  Angiogenesis stimulant
0,327  0,052  Antineoplastic (osteosarcoma)
0,288  0,018  Antiviral (Influenza A)
0,264  0,009  VEGF expression inhibitor
0,325  0,072  Immunostimulant
0,262  0,010  UGT2B1 substrate
0,260  0,011  UGT2B10 substrate
0,256  0,007  Microtubule formation inhibitor
0,260  0,017  Antihyperlipoproteinemic
0,246  0,004  Androgen agonist
0,264  0,026  Interferon gamma antagonist
0,265  0,029  Antiviral (Herpes)
0,289  0,055  Cardiodepressant
0,236  0,003  Potassium channel Kv1.3 blocker
0,244  0,019  Antifungal enhancer
0,253  0,030  Antiacne
0,233  0,010  Arachidonic acid antagonist
0,267  0,050  Mutagenic
0,243  0,030  Melanin inhibitor
0,224  0,013  Choleretic
0,218  0,007  Pregnane X receptor agonist
0,208  0,003  Anabolic
0,209  0,009  ABCA1 expression enhancer
0,212  0,018  Farnesoid X receptor antagonist
0,198  0,008  Estrogen agonist
0,222  0,034  Protein kinase stimulant
0,254  0,067  Vasodilator
0,220  0,034  Phospholipase C inhibitor
0,215  0,033  Interleukin 6 antagonist
0,217  0,039  Hair growth stimulant
0,191  0,015  Contraceptive female
0,177  0,007  UGT2B11 substrate
0,204  0,036  Skin whitener
0,175  0,009  SULT1E1 substrate
0,244  0,079  Antipyretic
0,226  0,063  VCAM1 expression inhibitor
0,167  0,005  Progesterone antagonist
0,202  0,041  Toxic, respiratory center
0,183  0,024  Antineoplastic antibiotic
0,163  0,005  Anticholelithogenic
0,179  0,025  Endometrios treatment
0,164  0,011  Postmenopausal disorders treatment
0,256  0,103  CTGF expression inhibitor
0,183  0,032  Antiviral (Hepatitis B)
0,184  0,034  Protein-tyrosine phosphatase 1B inhibitor
0,243  0,094  Spasmolytic
0,170  0,022  Antineoplastic alkaloid
0,178  0,031  Adenylate cyclase inhibitor
0,196  0,048  Protein-tyrosine phosphatase inhibitor
0,257  0,111  Interleukin 2 agonist
0,152  0,007  Glycine receptor agonist
0,175  0,030  Adenylate cyclase stimulant
0,260  0,116  Angiogenesis inhibitor
0,159  0,017  Toll-Like receptor 4 antagonist
0,160  0,020  Estrogen antagonist
0,207  0,067  Platelet adhesion inhibitor
0,146  0,008  Glycine receptor antagonist
0,159  0,020  Hedgehog signaling inhibitor
0,166  0,031  Growth stimulant
0,188  0,054  Antirickettsial
0,204  0,070  Sedative
0,193  0,061  LDLR expression enhancer
0,136  0,004  RNA-directed RNA polymerase stimulant
0,135  0,004  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,182  0,058  Antineoplastic (bone cancer)
0,218  0,097  DNA synthesis inhibitor
0,184  0,066  Growth hormone agonist
0,144  0,038  Alcohol dehydrogenase substrate
0,147  0,051  Ca2+-transporting ATPase inhibitor
0,104  0,008  Estrogen receptor alpha agonist
0,102  0,009  Opioid kappa receptor agonist
0,237  0,147  Vasodilator, coronary
0,122  0,031  Actinic keratosis treatment
0,120  0,032  Estrogen receptor beta antagonist
0,116  0,027  Transcription factor NF kappa B stimulant
0,137  0,052  Monophenol monooxygenase inhibitor
0,093  0,010  H+/K+-transporting ATPase inhibitor
0,094  0,010  5-Alpha-reductase inhibitor
0,088  0,004  Microtubule stabilization
0,139  0,058  Antihemorrhagic
0,089  0,009  Lipocortins synthesis agonist
0,087  0,008  Acetyl-CoA transferase 2 inhibitor
0,086  0,010  Postcoital contraceptive
0,171  0,095  Antiarrhythmic
0,149  0,074  NOS3 expression enhancer
0,141  0,067  Bone formation stimulant
0,132  0,060  DNA polymerase I inhibitor
0,075  0,004  Glucose-6-phosphate dehydrogenase inhibitor
0,098  0,028  Estrogen receptor alpha antagonist
0,194  0,126  Interleukin agonist
0,099  0,035  Antiprotozoal activity enhancer
0,180  0,116  Antineoplastic (lymphocytic leukemia)
0,185  0,123  RNA-directed DNA polymerase inhibitor
0,114  0,052  Antiinfertility, female
0,080  0,025  SULT2A1 substrate
0,165  0,111  Growth factor agonist
0,070  0,016  Estrogen receptor beta agonist
0,060  0,010  Farnesoid X receptor agonist
0,109  0,060  Expectorant
0,054  0,005  HMG CoA reductase inhibitor
0,099  0,051  Bile acid receptor antagonist
0,086  0,037  CDC25A inhibitor
0,064  0,018  Estradiol 17 beta-dehydrogenase inhibitor
0,170  0,124  Free radical scavenger
0,084  0,043  Antibiotic
0,195  0,155  Antimycobacterial
0,067  0,028  Botulinum neurotoxin type A inhibitor
0,171  0,133  Tumour necrosis factor alpha release inhibitor
0,048  0,009  Tubulin agonist
0,048  0,011  Cholesterol absorption inhibitor
0,062  0,029  Protein 50S ribosomal subunit inhibitor
0,068  0,036  Nitric oxide donor
0,155  0,123  Antihypertriglyceridemic
0,123  0,091  Psychosexual dysfunction treatment
0,095  0,064  Lanosterol 14 alpha demethylase inhibitor
0,082  0,052  Acetylcholine nicotinic antagonist
0,043  0,014  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,108  0,080  Alkylator
0,044  0,017  Glucocorticoid antagonist
0,102  0,076  SULT1A1 substrate
0,109  0,084  Aldehyde dehydrogenase inhibitor
0,049  0,024  Liver X receptor agonist
0,031  0,007  Progesterone agonist
0,046  0,022  Hypogonadism treatment
0,087  0,063  ATPase (Vacuolar H+) inhibitor
0,031  0,010  Hedgehog signaling activator
0,100  0,080  Interleukin 1b antagonist
0,061  0,044  Heme oxygenase stimulant
0,080  0,064  Antiviral (Trachoma)
0,123  0,109  Eye irritation, high
0,085  0,071  Thioredoxin inhibitor
0,031  0,017  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,024  0,011  Corticosteroid-like
0,114  0,101  Antiparkinsonian, tremor relieving
0,166  0,155  Peptidyltransferase inhibitor
0,018  0,009  Vitamin D receptor agonist
0,153  0,144  Antialcoholic
0,049  0,041  Anesthetic inhalation
0,043  0,037  Parathyroid hormone antagonist
0,018  0,011  Telomerase stimulant
0,021  0,015  Estrone sulfatase inhibitor
0,125  0,122  Liver fibrosis treatment
0,098  0,094  Cell adhesion inhibitor
0,006  0,004  Transcortin receptor antagonist
0,041  0,040  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,020  0,020  Vitamin D receptor antagonist

